Vaccine Manufacture and Supply – News and Features

Spider silk has created something of a furor in the biomanufacturing world as businesses look for ways to cheaply scale up silk production.

The ability to obtain pure proteins is essential for developing drugs, creating vaccines and understanding biological processes. In this article, we discuss what a typical protein purification protocol involves and the various techniques used.

Scott Ripley explores how realizing the potential of mRNA therapeutics will require the standardization of processes, manufacturing agility and collaboration between industry, academia and government bodies.

Vaccines are the most cost-effective strategy to prevent and suppress global infections. This article explores innovative strategies and technologies shaping the production of vaccines, ensuring rapid development, scalability and global accessibility.

A type of nanoparticle can activate a powerful immune response, showing promise for use as both the vaccine delivery system and as an adjuvant.

Encouraging scientists to rethink the materials and methods they use will help to foster a culture of sustainability within research institutions and across various industries. Technology Networks spoke with Dr. Joel Eichmann from Green Elephant Biotech to learn more about the creation of its plant-based plastic labware, and his broader vision for embedding sustainability within the biotech industry.

Cameroon today launched the RTS,S malaria vaccine into its routine national immunization services, becoming the first country to do so outside the malaria vaccine pilot programme that was carried out in Ghana, Kenya and Malawi.

A newly developed vaccine could offer an inexpensive way to lower "bad" cholesterol, improving heart health.

The first national study of its kind suggests that most US parents plan to vaccinate their children against influenza, COVID-19 and respiratory syncytial virus.

This article explores how biopharmaceutical organizations seeking to remain competitive must adopt innovations, like cell-free long DNA synthesis, to unleash the potential of synthetic biology and accelerate therapeutic development across all facets of genetic medicine.